Authors’ response to letter to editor—silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis

Atreya R, Neurath M (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Inflammatory Bowel Diseases Wiley

Book Volume: 32

Pages Range: 1426-1427

Journal Issue: 7

DOI: 10.1093/ibd/izag077

Authors with CRIS profile

Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen Markus Neurath Lehrstuhl für Innere Medizin I (Medizin 1)

How to cite

APA:

Atreya, R., & Neurath, M. (2026). Authors’ response to letter to editor—silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis. Inflammatory Bowel Diseases, 32(7), 1426-1427. https://doi.org/10.1093/ibd/izag077

MLA:

Atreya, Raja, and Markus Neurath. "Authors’ response to letter to editor—silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis." Inflammatory Bowel Diseases 32.7 (2026): 1426-1427.

BibTeX: Download